DarioHealth Corp.

Healthcare

NASDAQ:DRIO · NASDAQ Capital Market

Market Cap $52.14M Beta 1.08 P/E (TTM) 5.5

$6.93 -1.68%

-$0.12 today

52W Low $5.94High $17.74

Vol 0.00M · Avg 0.01M

EPS (TTM) $1.26Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-49.42%

Period High

$17.35

Period Low

$6.17

Latest

$6.93

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

InnovAge Holding Corp.

NASDAQ:INNV

$1.26B

Avanos Medical, Inc.

NYSE:AVNS

$1.17B

Absci Corporation

NASDAQ:ABSI

$1.13B

Anbio Biotechnology Class A Ordinary Shares

NASDAQ:NNNN

$737.37M

Fulgent Genetics, Inc.

NASDAQ:FLGT

$516.18M

Pacific Biosciences of California, Inc.

NASDAQ:PACB

$436.99M

Myriad Genetics, Inc.

NASDAQ:MYGN

$428.92M

REGENXBIO Inc.

NASDAQ:RGNX

$420.76M

Orthofix Medical Inc.

NASDAQ:OFIX

$379.23M

Verastem, Inc.

NASDAQ:VSTM

$286.96M

What is the latest DRIO filing?

The latest filing shown is 10-Q dated May 13, 2026.

How many recent filings does DRIO have?

Intrinsic Alpha currently shows 20 recent filings for DRIO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.